65,437 trials
Colonic Polyps
Primary: Diagnostic Accuracy of In-vivo Polyp Assessment — 93.3; 94.7 % diagnostic accuracy
HBV (Hepatitis B Virus) · Hepatitis B · Hepatitis
Primary: Maintained Combined Response (Virological, Biochemical and Histological Response). — 15; 6; 7; 13 participants — p=0.0294
Influenza
Primary: Number of Subjects Reporting at Least One Confirmed Occurrence of Influenza A or B. — 58; 128 subjects
Bipolar Depression
Primary: Mean Change From Baseline in the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score at Endpoint (Week 6) — -17.1; -13.5 units on a scale — p=0.005
Metastatic Breast Cancer
Primary: Objective Response Assessed by the Independent Review Facility Using Response Evaluation Criteria in Solid Tumors (RECIST) — 25.7; 26.9 Percentage of patients
Lumbar Spinal Stenosis
Primary: Pain as Measured by Visual Analog Scale (VAS). — 2.17 units on a scale — p=<0.0001
Tinnitus
Primary: Adverse Events — 0 participants
Arrhythmia
Primary: Atrial Fibrillation — 6; 1 participants
Stage III Squamous Cell Carcinoma of the Hypopharynx · Stage III Squamous Cell Carcinoma of the Larynx · Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
Primary: Comparison of the Percentage of Participants With a Complete Response in Each Treatment Arm — 42; 51 percentage of participants
Alzheimer's Disease · Huntington's Disease
Primary: Balance of Effects- Drug Liking VAS: Peak Effect (Maximum Effect [Emax]) and Minimum Effect (Emin) — 57.8; 78.6; 82.2; 57.2 mm — p=<0.0001
Autism · Asperger's Syndrome · Generalized Anxiety Disorder
Primary: Pediatric Anxiety Rating Scale (Measures the Severity of Anxiety Symptoms) — 16.33; 17.62; 11.58; 16.05 units on a scale
Poliomyelitis · Tetanus · Acellular Pertussis
Primary: Number of Seroprotected Subjects for Anti-diphtheria (Anti-D) and Anti-tetanus (Anti-T) Antibodies. — 213; 217; 213; 217 Participants
Breast Cancer
Primary: Median Progression-Free Survival — 10.4 months
Nerve Block, Intercostal Nerve
Primary: Postoperative Analgesic (Tramadol) Consumption
Diabetes
Primary: Systolic Blood Pressure Before and After Treatment — 121.0; 124.1; 112.1; 121.5 mm Hg